证券代码：688231 证券简称：隆达股份 公告编号：2025-022 江苏隆达超合金股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/6/10 | 2025/6/11 | 2025/6/11 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经江苏隆达超合金股份有限公司（以下简称"公司"）2025 年 5 月 16 日的2024年年度股东大会审议通过。 二、 分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东， 江苏隆达超合金股份有限公司（以下简称"公司"）回购专用证券账户除外。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所 是否涉及差异化分红送转：是 每股分配比例 每股现 ...

Core Viewpoint - Longda Co., Ltd. is intensifying its investment in overseas subsidiaries to advance its internationalization strategy, particularly through a $40 million increase in investment in its Singapore subsidiary, Singda Superalloy PTE. LTD. [1][5] Investment Strategy - Longda Co., Ltd. plans to invest an additional $40 million in its Singapore subsidiary to enhance overseas manufacturing capacity, upgrade equipment, and improve local operational systems [1][3] - The total investment in the Singapore subsidiary will rise from $20 million to $60 million following this additional investment [3] Financial Performance - As of the end of March, Longda Co., Ltd. had cash reserves of 175 million yuan (approximately $25 million) and discounted receivables of about 200 million yuan (approximately $29 million), which can be utilized for the increased investment [1][3] - In 2024, Longda Co., Ltd. reported overseas revenue of 262 million yuan (approximately $38 million), a year-on-year increase of 167.82% [7] - The company's gross margin for overseas markets reached 29.8%, an increase of 7.1 percentage points year-on-year [7] Market Expansion - The establishment of the Singapore subsidiary is part of Longda Co., Ltd.'s strategic development plan to create an international operational platform, including a business headquarters and R&D center in Southeast Asia [2] - The company is expanding its product lines to include corrosion-resistant alloys and high-performance special deformation alloys to meet international customer demands [3] Recent Developments - Longda Co., Ltd. has completed the acquisition of land for its Malaysian subsidiary, which is set to begin construction in July 2025 [2][4] - The company has seen a recovery in its performance, with 2024 revenues reaching 1.391 billion yuan (approximately $200 million), a 15.22% increase year-on-year, and a net profit of 66.11 million yuan (approximately $9.5 million), up 19.38% [6][8]

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

Core Viewpoint - The company, Jiangsu Longda Superalloy Co., Ltd., is increasing its investment in its wholly-owned subsidiary in Singapore, Singda Superalloy Pte. Ltd., by $40 million to enhance its overseas manufacturing capacity and product offerings [1][4]. Investment Overview - The total investment in the Singapore subsidiary will rise from $20 million to $60 million following this additional investment [4]. - The additional $40 million will be allocated for expanding factory infrastructure, upgrading key production and testing equipment, supplementing operational funds, and improving the local supply chain [4]. Project Development - The Singapore subsidiary has established a wholly-owned subsidiary in Malaysia, Singda Superalloy (Malaysia) Sdn. Bhd., which is set to begin construction in July 2025 with a projected construction period of 15 months [3]. - The project will include the production of high-temperature alloy master alloys, corrosion-resistant nickel-based alloys, and other specialized alloys [3]. Financial Position - As of the end of the first quarter of 2025, the company reported cash and cash equivalents of approximately 175 million yuan (about $25 million) available for this investment [4]. - The company has also secured a total bank credit line of 120 million yuan (approximately $17 million) to support its operational needs [4]. Decision-Making Process - The investment decision was approved by the company's board of directors with unanimous support, and it does not require shareholder approval as it falls within the board's authority [5].

证券代码：688231 证券简称：隆达股份 公告编号：2025-021 江苏隆达超合金股份有限公司 关于对新加坡全资子公司增加投资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 1、江苏隆达超合金股份有限公司（以下简称"公司"或"隆达股份"）本 次对新加坡全资子公司 SINGDA SUPERALLOY PTE. LTD.（以下简称"新达公 司"）增加投资事宜尚需履行境内对境外投资的审批或备案等手续，能否顺利 实施存在不确定性。 2、鉴于本次增加投资的资金来源均为自有资金，可能存在自有资金实际投 入与项目计划所需资金投入进度不匹配的风险，公司将持续关注项目建设进度， 合理安排资金支出。 3、因受宏观经济、行业发展、政策等因素影响，可能会出现项目实际建设 进度及投产后产能利用不达预期的风险，导致本次项目投资收益存在不确定性， 公司将进一步强化对项目的管理工作，持续关注相关子公司的经营状况及管理 成果，积极防范应对和控制上述风险。 一、对外投资及其进展情况的概述 公司于 2024 年 1 月 16 日召开 ...

证券代码：688231 证券简称：隆达股份 公告编号：2025-020 江苏隆达超合金股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 5 月 16 日 （二） 股东大会召开的地点：无锡市锡山区安镇街道翔云路 18 号，隆达股份公 司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 59 | | --- | --- | | 普通股股东人数 | 59 | | 2、出席会议的股东所持有的表决权数量 | 120,964,627 | | 普通股股东所持有表决权数量 | 120,964,627 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 49.0018 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 49.0018 | ...

北京大成(上海)律师事务所 关于江苏隆达超合金股份有限公司 2024 年年度股东大会的 = 法律意见书 大成 DENTONS 大成 is Dentons' Preferred Law Firm in China. 北京大成(上海)律师事务所 www.dacheng.com 上海市世纪大道 100 号环球金融中心 9 层、24 层、25 层(200120) 9th/24th/25th Floor, Shanghai World Financial Center, 100 Century Avenue Shanghai 200120, P. R. China Tel: +86 21 5878 5888 Fax: +86 21 5878 6866 江苏隆达超合金股份有限公司 2024年年度股东大会法律意见书 江苏隆达超合金股份有限公司 2024年年度股东大会法律意见书 北京大成(上海)律师事务所 关于江苏降达韶合金股份有限公司 2024 年年度股东大会的法律意见书 致:江苏隆达超合金股份有限公司 根据《中华人民共和国证券法》(以下简称"《证券法》")《中华人民共和国 公司法》(以下简称"《公司法》")和中国证券监督 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company [1] Core Insights - In 2024, the company achieved a revenue of 1.391 billion yuan, a year-on-year increase of 15.22%, and a net profit attributable to shareholders of 66.114 million yuan, up 19.38% year-on-year [1][4] - The company's non-recurring net profit saw a significant increase of 51.21% year-on-year, reaching 44.381 million yuan [1] - The first quarter of 2025 showed a revenue of 344 million yuan, reflecting an 8.67% year-on-year growth, with a net profit of 28.539 million yuan, up 3.20% year-on-year [1] Financial Performance - The company reported a gross margin of 15.88% in 2024, an increase of 0.51 percentage points year-on-year, and a net margin of 4.75%, up 0.17 percentage points year-on-year [4] - The revenue from high-temperature alloys reached 897 million yuan, a year-on-year increase of 23.96%, with a production volume of 4,013.71 tons, up 28.28% year-on-year [4] - The aerospace sector generated 435 million yuan in revenue, a 46.64% increase year-on-year, while the gas turbine sector saw a revenue increase of 67.34% to 267 million yuan [4] International Expansion - The company is actively expanding its international presence, with overseas revenue reaching 262 million yuan, a remarkable year-on-year increase of 167.84% [4] - The establishment of production bases in Singapore and Malaysia is underway, with land transaction contracts signed for the Malaysian facility [5] Future Projections - The company forecasts net profits of 99 million yuan, 129 million yuan, and 162 million yuan for 2025, 2026, and 2027 respectively, with corresponding PE ratios of 41, 31, and 25 [5][6] - Revenue is expected to grow to 1.75 billion yuan in 2025, reflecting a 26% year-on-year increase [6]

Group 1 - Shengyi Electronics plans to repurchase shares with a total amount between 50 million and 100 million yuan, at a price not exceeding 43.02 yuan per share, for employee stock ownership plans [1] - Guoyao Modern's subsidiary has passed the consistency evaluation for the quality and efficacy of a generic drug, which is used for treating severe infections [1] - Tianhe Magnetic Materials' subsidiaries have obtained project filing notices for high-performance rare earth permanent magnet projects, with total investments of 100 million yuan and 50 million yuan respectively [1][2] Group 2 - Dream Lily intends to repurchase shares with an amount between 85 million and 170 million yuan, at a price not exceeding 10.90 yuan per share, supported by a loan commitment of up to 150 million yuan [3] - Weifu High-Tech has received a loan commitment of up to 135 million yuan from a financial institution for share repurchase [3] Group 3 - Lu'an Environmental Energy reported a coal sales volume of 4.51 million tons in April, a year-on-year increase of 17.75% [5] - *ST Tianshan reported a significant decline in livestock sales and revenue, with a revenue of 70,500 yuan in April, down 95.68% year-on-year [7] Group 4 - Feirongda announced a cash dividend of 0.38 yuan per 10 shares, with a total distribution of 21.9 million yuan [8] - Zhejiang Rongtai's shareholders and executives plan to reduce their holdings by up to 1.93% of the company's shares [9] Group 5 - Changhua Group's subsidiary won the land use rights for an industrial site in Ningbo for 27.05 million yuan, intended for manufacturing and related business [11] - Zejing Pharmaceutical's new drug application for a treatment for severe alopecia has been accepted by the regulatory authority [13][14] Group 6 - Hainan Mining plans to distribute a cash dividend of 0.8 yuan per 10 shares, totaling 1.59 billion yuan [15] - China Jushi plans to distribute a cash dividend of 0.24 yuan per share, totaling 9.61 billion yuan [16] Group 7 - Zhengzhong Design's subsidiary has obtained a utility model patent for an acrylic signage guide [18] - Rundu Co., Ltd. received approval for a veterinary drug product, which is intended for treating bacterial diseases in livestock [20] Group 8 - Emei Mountain A announced the resignation of its general manager due to work reasons [22] - Tonghua Dongbao's insulin injection has received a registration certificate in Nicaragua, allowing for sales in that market [23] Group 9 - Dizu Fashion's subsidiary has completed the registration of a private equity investment fund [24] - Ningbo Gaofa plans to increase capital by 60 million yuan in its subsidiary for operational needs [26] Group 10 - Haichuan Intelligent has obtained two utility model patents for material handling devices [27] - Newland's subsidiary signed a deep cooperation agreement with Alibaba Cloud for AI model applications [29] Group 11 - Rui Neng Technology's controlling shareholder plans to reduce its stake by up to 2.89% [30] - Guomai Culture intends to repurchase shares between 50 million and 100 million yuan for capital reduction [31] Group 12 - Shaanxi Construction won major construction projects totaling 7.88 billion yuan in April [32] - Hanyu Pharmaceutical signed a joint development agreement for a new peptide drug with a partner [34] Group 13 - Yunnan Copper is planning to acquire a 40% stake in Liangshan Mining, leading to a stock suspension [35] - Haizheng Pharmaceutical plans to repurchase shares between 50 million and 100 million yuan for employee stock ownership [36] Group 14 - Tianqiao Hoisting's controlling shareholder plans to increase its stake by 75 million to 150 million yuan [37] - Tiandi Online's controlling shareholder is transferring shares to introduce a strategic investor [38] Group 15 - Hongchang Technology plans to invest 15 million yuan in a joint venture with a partner [39] - Rabbit Baby's subsidiary is preparing for an IPO in Hong Kong [41] Group 16 - Wol Nuclear Materials is planning to issue H-shares for listing in Hong Kong [42] - Tangyuan Electric plans to raise up to 864 million yuan through a private placement for various projects [43] Group 17 - Tongrun Equipment's major shareholders plan to reduce their holdings by up to 2% [44] - Linzhou Heavy Machinery plans to raise up to 600 million yuan through a private placement [46] Group 18 - China Merchants Securities announced the resignation of its vice president [47] - Shangsheng Electronics plans to issue convertible bonds to raise up to 330 million yuan for various projects [48] Group 19 - Longda Co., Ltd.'s major shareholder plans to reduce its stake by up to 1% [49] - China Medical plans to acquire 100% of Jinsui Technology for 302 million yuan [50] Group 20 - Silek has signed a strategic cooperation agreement with a battery manufacturer [51] - Boyun New Materials' major shareholder plans to reduce its stake by up to 3% [53]

Group 1 - The major shareholder, Wuxi Guolian Industrial Upgrade Investment Center, plans to reduce its stake in Longda Co., Ltd. by up to 2,468,571 shares, which is no more than 1% of the total share capital [1] - As of the announcement date, Guolian holds 21,556,321 shares, accounting for 8.73% of the total share capital [1] - The reduction will occur through centralized bidding within three months after the announcement, with a limit of 1% of total shares in any consecutive 90-day period [1] Group 2 - Longda Co., Ltd. was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 22, 2022, with an initial offering price of 39.08 yuan [3] - The company raised a total of 241,179.43 million yuan from its initial public offering, with a net amount of 220,127.16 million yuan, exceeding the original plan by 120,127.16 million yuan [3] - The funds raised are intended for a technical transformation project to increase the annual production of aviation-grade high-temperature alloys by 10,000 tons, a new research and development center, and to supplement working capital [3]